Unique 2D codes for every unit ensure real-time tracking within the market.
Smart aggregation enables precise shipment tracking across the supply chain.
Gradual implementation of the system with full technical support for all parties
........................................................................
EDA held an introductory lecture to explain the operational mechanism of the Pharmaceutical Track and Trace system and to enhance the ways of its implementation across all stages of the pharmaceutical products marketing, supporting efforts to tighten control over the Egyptian pharmaceutical market as part of a series of events scheduled to be organized over several days, with the participation of representatives from pharmaceutical companies and warehouses, and in the presence of representatives from DAF Digital Solutions.
These sessions serve to review the framework of the Track and Trace system, which is considered one of the fundamental pillars for enhancing oversight of the pharmaceutical market. The system relies on Unique Identification Codes for every unit, allowing for comprehensive monitoring from manufacturing to patient delivery, thereby contributing to ensuring the quality of the pharmaceutical products in circulation.
The Pharmaceutical Track and Trace system aims to enhance transparency in pharmaceutical product trading and ensure the delivery of safe and effective pharmaceutical products to patients, in addition to supporting digital transformation efforts and developing the infrastructure of the healthcare sector in Egypt.
The events addressed the executive requirements for implementing the Track and Trace system for pharmaceutical companies and distribution companies. They reviewed the regulatory and technical controls that manufacturing and importing companies must adhere to, which include applying a coding system using a 2D barcode on the outer packaging of products before market release. This barcode includes essential identification data such as the product code, batch number, expiration date, and a unique serial number for each pack, with the necessity of printing it clearly to ensure it can be easily read electronically, in addition to the commitment to printing additional data including the production date, price, importer information, and the registration number with the EDA, while ensuring that imported products comply with the approved coding requirements.
The sessions also covered the technical requirements for using the "Aggregation" system to link individual packs to larger containers, enabling integrated shipment tracking. Furthermore, electronic data exchange (including serial lists and aggregation data) must be conducted in approved digital formats before shipping.
The lecture also reviewed the implementation requirements for distribution companies and pharmaceutical products warehouses, which include possessing digital systems, maintaining digital systems compatible with the national platform to record receipts within 48 hours, and linking them to aggregation codes and GLN codes, also verifying the integrity and sequence of codes before shipping or decommissioning, alongside real-time registration of shipping operations with recording all shipping movements instantaneously.
The lecture also included additional controls to ensure the integrity of the system, most notably halting the trading of any pack containing a code that is unreadable or unverifiable. Additionally, it stressed the necessity of using the approved spatial code for each pharmacy, which contributes to tightening control over pharmaceutical product marketing and enhancing the efficiency of the pharmaceutical supply chain.